How long the cirrhosis digestive bleeding can live depends on the patient’s bleeding volume, whether repeated bleeding, whether combined with other liver diseases and whether to reach the liver function Child C grade and other factors related to the patient, the general survival time is several years or even more than ten years.
1. Upper gastrointestinal bleeding is the most common complication in patients with cirrhosis, which is caused by esophagogastric fundal varices (EGVB), peptic ulcer and portal hypertensive gastroenteropathy. If the patient bleeds heavily and repeatedly, causing shock and hepatic encephalopathy and without timely treatment, the patient is very likely to die. If the patient is combined with other liver diseases or the liver function has reached ChildC grade, the prognosis is also poor.
2. If the patient has less bleeding and actively cooperates with the doctor for digestive hemostasis and treatment of cirrhosis, the five-year survival rate is higher. the main treatment means for EGVB patients are drug therapy, endoscopic treatment, transjugular intrahepatic portosystemic shunt (TIPS), etc.
(1) Pharmacological treatment: EGVB patients can use growth inhibitors, octreotide, pituitary pressor, etc. The first two drugs are not suitable for EGVB patients because of their effects on systemic blood pressure. The first two drugs are commonly used in patients with EGVB due to their lesser impact on systemic hemodynamics and fewer adverse effects.
(2) Endoscopic treatment: If the patient’s bleeding is moderate or less, endoscopic ligation treatment is urgently used, which is applicable when the patient has simple esophageal varices but no fundic varices.
(3) TIPS: For patients with major bleeding. TIPS should be used within 3 days if the patient is hemorrhaging and the probability of success of endoscopic treatment is assessed to be low.
Patients are advised to use medication and treatment under the supervision of a physician.